JP2007504225A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504225A5
JP2007504225A5 JP2006525335A JP2006525335A JP2007504225A5 JP 2007504225 A5 JP2007504225 A5 JP 2007504225A5 JP 2006525335 A JP2006525335 A JP 2006525335A JP 2006525335 A JP2006525335 A JP 2006525335A JP 2007504225 A5 JP2007504225 A5 JP 2007504225A5
Authority
JP
Japan
Prior art keywords
acid
omega
lipid system
fatty
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006525335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504225A (ja
JP5745734B2 (ja
Filing date
Publication date
Priority claimed from US10/656,662 external-priority patent/US7759507B2/en
Application filed filed Critical
Publication of JP2007504225A publication Critical patent/JP2007504225A/ja
Publication of JP2007504225A5 publication Critical patent/JP2007504225A5/ja
Application granted granted Critical
Publication of JP5745734B2 publication Critical patent/JP5745734B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006525335A 2003-09-05 2004-08-04 脂質系および使用方法 Expired - Fee Related JP5745734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/656,662 US7759507B2 (en) 2003-09-05 2003-09-05 Lipid system and methods of use
US10/656,662 2003-09-05
PCT/US2004/025161 WO2005025334A1 (en) 2003-09-05 2004-08-04 Lipid system and methods of use

Publications (3)

Publication Number Publication Date
JP2007504225A JP2007504225A (ja) 2007-03-01
JP2007504225A5 true JP2007504225A5 (enExample) 2015-05-21
JP5745734B2 JP5745734B2 (ja) 2015-07-08

Family

ID=34226392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006525335A Expired - Fee Related JP5745734B2 (ja) 2003-09-05 2004-08-04 脂質系および使用方法

Country Status (13)

Country Link
US (2) US7759507B2 (enExample)
EP (1) EP1662905A1 (enExample)
JP (1) JP5745734B2 (enExample)
KR (1) KR20060076766A (enExample)
CN (1) CN1874692B (enExample)
AU (2) AU2004271928B2 (enExample)
BR (1) BRPI0414096A (enExample)
CA (1) CA2536692C (enExample)
IL (1) IL173967A (enExample)
MX (1) MXPA06002481A (enExample)
NZ (1) NZ545470A (enExample)
WO (1) WO2005025334A1 (enExample)
ZA (1) ZA200602768B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344747B2 (en) * 2004-04-29 2008-03-18 Gfa Brands, Inc. Oxidative stabilization of omega-3 fatty acids in low linoleic acid-containing peanut butter
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
CA2616806A1 (en) * 2005-07-28 2007-02-08 Reliant Pharmaceuticals, Inc. Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2007132888A1 (ja) * 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology 平滑筋収縮抑制剤
MY148528A (en) * 2006-12-28 2013-04-30 Nisshin Oillio Group Ltd Oil-and-fat composition, and food or beverage containing the oil-and-fat composition
US20090270502A1 (en) * 2007-01-11 2009-10-29 Carotino Sdn. Bhd. Method for Lowering Risk of Cardiovascular Diseases
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
US20080269328A1 (en) * 2007-04-09 2008-10-30 Mohammed Moghadasian Effects of low n-6:n-3 fatty acid ratio from two dietary sources on plasma and tissue lipid composition
EP2211881A4 (en) * 2007-11-01 2012-01-04 Wake Forest University School Of Medicine COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF SEDUCTIVES OF MAMMALS
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US20090155447A1 (en) * 2007-12-12 2009-06-18 Solae, Llc Protein extrudates comprising omega-3 fatty acids
US20110177224A1 (en) * 2008-03-03 2011-07-21 Daniel Perlman Stabilization of omega-3 fatty acids in oil-water emulsions
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US20100130608A1 (en) * 2008-10-01 2010-05-27 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
JP5407362B2 (ja) * 2009-01-26 2014-02-05 株式会社カネカ 水中油型乳化油脂組成物
SG173914A1 (en) * 2009-04-01 2011-10-28 Nestec Sa Reduction of risk of obesity
US20100272875A1 (en) * 2009-04-24 2010-10-28 Monsanto Technology Llc Omega-3 enriched cereal, granola, and snack bars
JP2009219500A (ja) * 2009-06-22 2009-10-01 Suntory Holdings Ltd 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US11986508B1 (en) 2010-04-06 2024-05-21 Juliana Konzny Nutritional and cosmetic product, system and method for use
CN101843336A (zh) * 2010-04-22 2010-09-29 王京南 亚麻油脂肪乳口服溶液、饮料及制造方法
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
US10682327B2 (en) 2011-04-17 2020-06-16 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2012145119A2 (en) * 2011-04-17 2012-10-26 Michael Gurin Low inflammatory blended oils
CA2857372C (en) * 2011-04-17 2021-07-06 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US10653160B2 (en) 2011-04-17 2020-05-19 Omega Foods, LLC Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids
US8551551B2 (en) 2012-01-06 2013-10-08 Perlman Consulting, Llc Stabilization of omega-3 fatty acids in saturated fat microparticles having low linoleic acid content
SG11201403805WA (en) 2012-01-06 2014-08-28 Omthera Pharmaceuticals Inc Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
AR095182A1 (es) 2012-05-07 2015-09-30 Omthera Pharmaceuticals Inc Composiciones de estatinas y ácidos grasos omega-3
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
BR112015001884B1 (pt) * 2012-07-31 2020-12-01 Société des Produits Nestlé S.A. composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida
CN104247787A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合普健康经济型a级双合食用油
CN104247786A (zh) * 2013-06-26 2014-12-31 孙志刚 一种正营养动植物油混合健康双合食用油
CN104413167A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量35克以上人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413170A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量25-30克人群24种正营养食用油各种健康指标的脂肪酸科学配比
CN104413168A (zh) * 2013-08-20 2015-03-18 孙志刚 一种日摄入量30-35克人群24种正营养食用油各种健康指标的脂肪酸科学配比
EP3190099B1 (de) 2015-09-14 2020-10-28 Helmholtz-Zentrum Potsdam - Deutsches GeoForschungsZentrum GFZ Stiftung des Öffentlichen Rechts des Lands Brandenburg Neue fettsäure und ihre verwendung
BR102016016559A2 (pt) * 2016-07-18 2018-02-06 Francisco Pianowski Luiz Apresentação de cloreto de magnésio ingerível
CA3266331A1 (en) * 2022-09-01 2024-03-07 Univ Zuerich Lipid emulsion with anti-inflammatory effects for total parenteral and enteral nutrition
CN116058417A (zh) * 2022-11-25 2023-05-05 新疆札郎孜生物科技有限公司 一种植物调和油及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4526902A (en) 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5059622A (en) 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB2223943A (en) 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
US5922345A (en) 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
JPH0745616A (ja) * 1993-07-29 1995-02-14 Nec Corp 半導体装置の製造方法
EP0639333B1 (fr) 1993-08-20 1999-11-03 Societe Des Produits Nestle S.A. Composition lipidique à usage alimentaire
EP0754001B1 (en) 1994-04-01 2002-01-23 Abbott Laboratories Nutritional product for treatment of ulcerative colitis and use thereof
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5780451A (en) 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
DE4417851C1 (de) 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
JP3840670B2 (ja) 1995-01-27 2006-11-01 味の素株式会社 糖尿病患者用脂肪輸液剤
US5895652A (en) 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5922704A (en) 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
EP1082028B1 (en) 1998-06-03 2002-05-15 The State Of Israel-Ministry Of Agriculture Matthiola seed oil, mixtures containing it and use thereof
AU5678699A (en) 1998-08-27 2000-03-21 Bowles Fluidics Corporation Water bottle with drinking and spray modes
JP3998355B2 (ja) * 1998-11-26 2007-10-24 日清オイリオグループ株式会社 食用油
AUPQ228199A0 (en) 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
JP4391673B2 (ja) * 2000-08-08 2009-12-24 花王株式会社 油脂組成物
DE60143753D1 (de) 2000-08-08 2011-02-10 Kao Corp Öl-/fett-zusammensetzung
US6432453B1 (en) 2000-08-26 2002-08-13 Metagenics, Inc. Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid
DE60104450T2 (de) * 2000-09-21 2005-09-15 Nutrition 21, Inc. Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils
DE10130491A1 (de) 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
CN1339262A (zh) 2001-09-21 2002-03-13 阮生 食用香油

Similar Documents

Publication Publication Date Title
JP2007504225A5 (enExample)
Calder Fatty acids and inflammation: the cutting edge between food and pharma
Calder Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Wall et al. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids
Saini et al. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance—A review
Echeverría et al. Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources
Mayer et al. Fish oil in the critically ill: from experimental to clinical data
Kimura et al. Long-term supplementation of docosahexaenoic acid-rich, eicosapentaenoic acid-free microalgal oil in n-3 fatty acid-deficient rat pups
JP2014512351A5 (enExample)
Bonafini et al. Beneficial effects of ω-3 PUFA in children on cardiovascular risk factors during childhood and adolescence
Chavali et al. Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil
WO2008147562A3 (en) Dietary formulations and methods for treatment of inflammation and other disorders
Kuhnt et al. Dietary Echium Oil Increases Long-Chain n–3 PUFAs, Including Docosapentaenoic Acid, in Blood Fractions and Alters Biochemical Markers for Cardiovascular Disease Independently of Age, Sex, and Metabolic Syndrome
DK1809125T3 (da) Næringsmiddel, der indeholder en fedtblanding
JP2021137035A5 (ja) 高度不飽和脂肪酸のトリグリセリドを含む組成物
Gazem et al. Omega fatty acids in health and disease: a review
JP2012509292A5 (enExample)
Minihane et al. Health benefits of polyunsaturated fatty acids (PUFAs)
Abozid et al. Effect of omega 3 fatty acids family in human health
JP2012508791A5 (enExample)
Dias et al. Kinetics of omega-3 polyunsaturated fatty acids when co-administered with saturated or omega-6 fats
US20190216762A1 (en) Vegetarian composition containing unsaturated fatty acids
Punia et al. Mechanism of action of essential fatty acids
Roy et al. Long chain polyunsaturated fatty acid (LC-PUFA) composition of fish sperm: nexus of dietary, evolutionary, and biomechanical drivers
JP3249657U (ja) フィッシュオイル配合物を含むソフトカプセル構造